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Microbial components play a major role in acti-
vating innate and adaptive immune responses by 
triggering  pattern  recognition  receptors  (Ishii   
et al., 2008). Poly(I:C) is an analogue of viral 
double-stranded RNA (dsRNA) that activates 
various immune cell types through two major 
dsRNA  sensors,  melanoma  differentiation-
associated protein-5 (MDA5) and Toll-like re-
ceptor 3 (TLR3). MDA5 is a cytosolic sensor, 
which detects poly(I:C) that penetrates into the 
cytosol through as yet undefined mechanisms 
(Ishii et al., 2008). TLR3 is located in intracel-
lular endosomes and detects poly(I:C) that has 
been internalized by endocytosis (Matsumoto 
and  Seya,  2008).  Upon  poly(I:C)  detection, 
MDA5 transmits signals through the adaptor 
IPS1, whereas TLR3 signals through the adap-
tor TRIF (also known as TICAM1). Both of 
these  adaptors  initiate  downstream  signaling 
pathways that lead to activation of a similar 
array of transcription factors, including IRF3, 
IRF7, IRF1, and NF-B. These factors induce 
the expression of genes encoding type I IFNs: 
i.e., IFN- and IFN-, proinflammatory cyto-
kines, and various molecules involved in antigen 
presentation (Kawai and Akira, 2008).
Poly(I:C) induces the maturation of DCs, 
boosting  their  ability  to  prime  and  expand   
antigen-specific T cell responses (Kumar et al., 
2008; Trumpfheller et al., 2008; Longhi et al., 
2009). Because of this DC stimulatory activity, 
poly(I:C) is a promising adjuvant for vaccines, 
particularly for cancer vaccines that must over-
come both tolerance to tumor-associated self-
antigens and the immunosuppressive influence 
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The double-stranded RNA (dsRNA) analogue poly(I:C) is a promising adjuvant for cancer 
vaccines because it activates both dendritic cells (DCs) and natural killer (NK) cells, concur-
rently promoting adaptive and innate anticancer responses. Poly(I:C) acts through two 
dsRNA sensors, Toll-like receptor 3 (TLR3) and melanoma differentiation-associated pro-
tein-5 (MDA5). Here, we investigated the relative contributions of MDA5 and TLR3 to 
poly(I:C)-mediated NK cell activation using MDA5/, TLR3/, and MDA5/TLR3/ mice. 
MDA5 was crucial for NK cell activation, whereas TLR3 had a minor impact most evident in 
the absence of MDA5. MDA5 and TLR3 activated NK cells indirectly through accessory cells 
and induced the distinct stimulatory cytokines interferon- and interleukin-12, respec-
tively. To identify the relevant accessory cells in vivo, we generated bone marrow chimeras 
between either wild-type (WT) and MDA5/ or WT and TLR3/ mice. Interestingly, mul-
tiple accessory cells were implicated, with MDA5 acting primarily in stromal cells and TLR3 
predominantly in hematopoietic cells. Furthermore, poly(I:C)-mediated NK cell activation 
was not notably impaired in mice lacking CD8 DCs, providing further evidence that  
poly(I:C) acts through diverse accessory cells rather than solely through DCs. These results 
demonstrate distinct yet complementary roles for MDA5 and TLR3 in poly(I:C)-mediated 
NK cell activation.
© 2009 McCartney et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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accessory cells that activate NK cells are indeed CD8 DCs, 
we examined mice deficient for the basic leucine zipper 
transcription factor ATF-like 3 (BATF3), which have a   
selective developmental defect in CD8 DCs (Hildner et al., 
2008). We found that poly(I:C)-mediated stimulation of   
NK cells was minimally affected in these mice, indicating 
that poly(I:C) acts through multiple accessory cells rather 
than solely through CD8 DCs. We conclude that MDA5 
and TLR3 mediate substantially distinct and yet comple-
mentary functions during poly(I:C)-mediated activation of 
NK cells.
RESULTS AND DISCUSSION
MDA5 has a predominant role in the NK cell response  
to poly(I:C) in vivo
To  investigate  the  relative  contributions  of  MDA5  and 
TLR3 in poly(I:C)-mediated activation of NK cells, we in-
jected WT, MDA5/, TLR3/, and MDA5/TLR3/ 
(double KO [DKO]) mice with poly(I:C); after 24 h, we 
isolated spleen NK cells and measured cytotoxicity ex vivo. 
NK cells from untreated WT and sensor-deficient mice were 
unable  to  kill  targets,  whereas  NK  cells  from  poly(I:C)-
treated WT mice killed up to 50% of targets (Fig. 1 A). NK 
cells from MDA5/ mice treated with poly(I:C) had a sig-
nificant defect in cytotoxicity, as only 20% of target cells 
were  killed  at  maximum  effector/target  ratios.  NK  cells 
from TLR3/ mice treated with poly(I:C) had a modest 
but not significant cytotoxicity defect. However, NK cells 
from DKO mice were unable to lyse targets after poly(I:C) 
stimulation. These results suggest that MDA5 can largely 
compensate for the lack of TLR3 and that TLR3 contri-
bution to NK activation is evident only in the absence   
of MDA5.
Another measure of NK cell activation is CD69 up-
regulation. CD69 is a cell surface molecule induced by 
IFN-/ that promotes lymphocyte retention in lymphoid 
of the tumor microenvironment (Steinman and Banchereau, 
2007). Poly(I:C) is also extensively used to activate mouse 
NK cells in vivo. The NK cell stimulatory activity of poly(I:C) 
is potentially important for anticancer vaccines, as it may 
contribute to tumor eradication by inducing NK cell–mediated 
lysis of tumor cells. In humans, the NK cell stimulatory 
activity of poly(I:C) has been chiefly attributed to its ability 
to trigger TLR3 expressed in cultured NK cells (Schmidt et al., 
2004; Sivori et al., 2004; Hart et al., 2005; Lauzon et al., 
2006). Whether poly(I:C) also activates human NK cells 
through DCs or other accessory cells has not been investi-
gated. In mice, poly(I:C) is thought to activate NK cells pri-
marily through DCs. An initial study showed that poly(I:C) 
stimulates TLR3 in DCs, which consequently acquire the 
ability to activate NK cells (Akazawa et al., 2007). A very 
recent study showed that poly(I:C) triggers both the TRIF 
and IPS1 signaling pathways in CD8 DCs, which in turn 
activate NK cells in vitro (Miyake et al., 2009). These results 
suggest that TLR3 and MDA5 may stimulate mouse NK 
cells  indirectly  through  activation  of  DCs,  particularly 
CD8 DCs.
In this study, we investigate the relative contributions of 
MDA5 and TLR3 in poly(I:C)-mediated activation of NK 
cells using MDA5/, TLR3/, and MDA5/TLR3/ 
mice. We find that MDA5 has a predominant role in NK 
cell activation, whereas the contribution of TLR3 is sec-
ondary and is most evident in the absence of MDA5. Both 
MDA5 and TLR3 activated NK cells indirectly through   
accessory cells but induced different NK cell stimulatory 
cytokines, as MDA5 was essential for IFN- and IFN-, 
whereas  TLR3  was  required  for  IL-12  and,  in  part,  for 
IFN-.  By  generating  BM  chimeras  between  WT  and   
dsRNA sensor-deficient mice, we found that MDA5 promotes 
NK cell activation mainly through stromal accessory cells, 
whereas TLR3 acts predominantly through BM-derived   
accessory cells. To determine whether the hematopoietic   
Figure 1.  Poly(I:C)-induced NK cell activation is primarily mediated by MDA5. WT, MDA5/, TLR3/, and DKO mice were injected with 100 µg 
poly(I:C) i.v. After 24 h, splenocytes were harvested and used as effector cells in a cytotoxicity assay with labeled RMA-S targets (experiment performed 
using one mouse for each genotype in four independent trials; A) or assayed for CD69 expression by FACS, gating on NK1.1+CD3 splenocytes (experi-
ment performed using two mice for each genotype in three independent trials; B). Alternatively, 3 or 4 h after poly(I:C) injection, splenocytes were iso-
lated, cultured with monensin for an additional 3 or 4 h, and analyzed for intracellular content of IFN- by FACS, gating on NK1.1+CD3 cells (experiment 
performed using one mouse for each genotype in three independent trials; C). Statistical significance is indicated by *, P < 0.05, **, P < 0.001, and ***,  
P < 0.0001. Error bars represent SD.JEM VOL. 206, December 21, 2009  2969
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MDA5 activates NK cells through  
an NK cell–extrinsic pathway
Because MDA5 is ubiquitously expressed, poly(I:C) could 
directly activate mouse NK cells through MDA5. However, 
MDA5 is also expressed in DCs, which play a crucial role in 
activating NK cells (Fernandez et al., 1999; Ferlazzo et al., 
2002; Gerosa et al., 2002; Andrews et al., 2003; Andoniou et 
al., 2005; Lucas et al., 2007; Mortier et al., 2008). Thus, 
poly(I:C) may activate mouse NK cells through DCs or other 
accessory cells expressing MDA5. To test whether MDA5-
mediated activation of mouse NK cells occurs in an NK-
intrinsic or -extrinsic manner, we co-cultured combinations of 
BMDCs and NK cells from WT or dsRNA sensor-deficient 
mice and measured cytotoxicity, CD69 up-regulation, and 
IFN- production in response to poly(I:C). Remarkably, the 
defect seen in NK cell activation in the MDA5/ mice in 
vivo was entirely recapitulated in the co-cultures of WT NK 
cells with MDA5/ BMDCs. MDA5/ BMDCs stimu-
lated with poly(I:C) promoted NK cytotoxicity, CD69 up-
regulation, and IFN- secretion less effectively than did 
poly(I:C)-activated WT BMDCs (Fig. 2, A–C). After exposure 
to poly(I:C), DKO BMDCs were almost entirely incapable of 
inducing NK activation. TLR3/ BMDCs stimulated with 
organs (Shiow et al., 2006). After injection of poly(I:C), 
CD69  up-regulation  was  partially  impaired  in  NK  cells 
from MDA5/ mice in comparison with those from WT 
mice and was completely abrogated in NK cells from DKO 
mice (Fig. 1 B). There was no decrease in CD69 expression 
in the TLR3/ mice, further implying that the effect of 
poly(I:C) is predominantly mediated by MDA5. To deter-
mine the contributions of MDA5 and TLR3 to NK cell 
production of IFN- in response to poly(I:C), we isolated 
splenocytes 3 and 4 h after injecting WT and dsRNA sen-
sor-deficient mice with poly(I:C) and determined the in-
tracellular content of IFN- in NK cells. NK cells isolated 
from both MDA5/ and TLR3/ mice 3 h after poly(I:C) 
injection produced less IFN- than WT NK cells (Fig. 1 C). 
However, by 4 h after poly(I:C) injection, TLR3/ and 
WT NK cells generated similar amounts of IFN-, whereas 
MDA5/ NK cells still produced less IFN- than either 
the TLR3/ or WT NK cells. DKO NK cells did not 
produce IFN- at any time point assessed after poly(I:C) 
stimulation.  All  together,  these  results  indicate  that   
MDA5 plays a more predominant role than TLR3 in stim-
ulating NK cytotoxicity, CD69 up-regulation, and IFN- 
production.
Figure 2.  MDA5 and TLR3 activate NK cells through NK cell–extrinsic mechanisms. BMDCs from WT, MDA5/, TLR3/, and DKO mice were 
cultured with purified NK cells from WT mice in the presence or absence of 25 µg poly(I:C). After 24 h, NK1.1+CD3 cells were stained for CD69 expression 
(A), and IFN- was measured from cultured supernatants (experiments were performed using BMDCs from one mouse for each genotype and NK cells 
from three pooled mice in four independent trials; B). Alternatively, Cr51-labeled RMA-S targets were added to culture, and cytotoxicity was measured 
(experiments were performed using BMDCs from one mouse from each genotype and NK cells from three pooled mice in three independent trials; C). In 
reverse experiments, BMDCs from WT mice were cultured with purified NK cells from WT or DKO mice with or without poly(I:C). After 24 h, CD69 expres-
sion was determined by FACS (D), IFN- was measured in supernatants (experiments were performed using BMDCs from one mouse and NK cells from 
three pooled mice of each genotype in four independent trials; E), and cytotoxicity was measured against RMA-S targets (experiments were performed 
using BMDCs from one mouse and NK cells from three pooled mice of each genotype in three independent trials; F). Statistical significance is indicated by 
*, P < 0.05, **, P < 0.001, and ***, P < 0.0001. Error bars represent SD.2970 Distinct roles of MDA5 and TLR3 in NK activation | McCartney et al.
/,  IL-12,  and  IL-18  stimulate  NK  cell  production  of 
IFN- (Trinchieri, 1995; Biron et al., 1999; Nguyen et al., 
2002;  Ferlazzo  and  Münz,  2004;  Andoniou  et  al.,  2005; 
Chaix et al., 2008); and IL-15 and IL-2 promote NK cell 
survival,  proliferation,  and  effector  functions  (Waldmann 
and Tagaya, 1999; Granucci et al., 2004; Koka et al., 2004; 
Lucas et al., 2007; Mortier et al., 2008). Because stimulation 
of both MDA5 and TLR3 with poly(I:C) leads to the pro-
duction of IFN-/ as well as inflammatory cytokines in 
DCs and other cells (Kawai and Akira, 2008), we predicted 
that the defect in NK activation in vivo would be associated 
with a defect in cytokine production in the absence of these 
dsRNA sensors. We found that serum IFN- was com-
pletely abolished in the MDA5/ and DKO mice 24 h after 
poly(I:C) stimulation (Fig. 3 A). In contrast, there was no 
defect in serum IFN- in TLR3/ mice compared with 
WT mice, which is consistent with previous studies (Kato   
et al., 2006; Kumar et al., 2008; Miyake et al., 2009). MDA5/ 
mice had WT levels of IL-12p40 in the serum, whereas serum 
IL-12p40 was completely abolished in TLR3/ and DKO 
serum 6 h after poly(I:C) stimulation (Fig. 3 B). Other cyto-
kines potentially relevant for NK cell activation, such as IFN-, 
IL-18, IL-1, IL-15, or IL-12p70, were undetectable in the   
serum of all mice after poly(I:C) stimulation.
Similar to our findings in the serum, we found that poly(I:C)-
stimulated MDA5/ and DKO BMDCs secreted less IFN- 
than did WT BMDCs (Fig. 3 C). TLR3 deficiency did not di-
minish but, in fact, slightly augmented the IFN- response. 
poly(I:C) induced less IFN- production in NK cells than 
did similarly treated WT BMDCs, whereas NK cell cytotox-
icity and CD69 expression were slightly augmented. No sig-
nificant differences in NK cytotoxicity, CD69 expression, 
and IFN- production were detected when NK cells from 
WT or DKO mice were co-cultured with poly(I:C)-activated 
WT BMDCs (Fig. 2, D–F). Consistent with this result, puri-
fied NK cells exhibited only modest or no increase in CD69 
expression  and  IFN-  secretion  when  directly  stimulated 
with poly(I:C), even when pretreated with IFN- and/or IL-12 
to induce MDA5 and TLR3 (Fig. S1). We conclude that 
poly(I:C)-induced NK activation through MDA5 and TLR3 
occurs extrinsic to the mouse NK cell itself. Moreover, although 
MDA5 deficiency in BMDCs severely impaired cytotoxicity 
and CD69 expression, TLR3 deficiency had a minor impact 
on these functions. In fact, TLR3 deficiency caused a slight 
increase of cytotoxicity and CD69 expression. These in vitro 
results further corroborate the concept that MDA5 plays a 
predominant role in mouse NK cell activation, whereas the 
contribution of TLR3 is limited but quite evident in the 
complete abrogation of NK activation observed in the DKO 
mice and cells.
MDA5 and TLR3 disparately promote the secretion  
of cytokines that stimulate NK cells
A variety of cytokines has been shown to activate NK cells. 
IFN-/ augments NK cell lytic capacity and expression of 
CD69 (Gerosa et al., 2002, 2005; Swann et al., 2007); IFN-
Figure 3.  MDA5 and TLR3 mediate distinct cytokine responses. WT, MDA5/, TLR3/, and DKO mice were injected with 100 µg poly(I:C) i.v.  
Serum was taken at 6 and 24 h and assayed for IFN- (experiment was performed with serum from five mice of each genotype in one independent ELISA 
assay; A) or IL-12p40 (experiment was performed with serum from four mice of each genotype in one independent ELISA assay; B) by ELISA. BMDCs from 
WT, MDA5/, TLR3/, and DKO mice were stimulated with 25 µg poly(I:C). At various time points after stimulation, supernatants were harvested, and 
IFN- (C), IFN- (D), and IL-12p40 (E) were measured by ELISA (experiments were performed with supernatants from BMDCs from each genotype in four 
independent experiments and evaluated by two independent ELISA assays). Statistical significance is indicated by *, P < 0.05, **, P < 0.001, and ***, P < 
0.0001. Error bars represent SD.JEM VOL. 206, December 21, 2009  2971
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certain extent, IFN-, but is not essential for IFN- production. 
Consistent with previous experiments in vivo (Longhi et al., 
2009), we found that poly(I:C)-induced NK cell activation in 
vitro was severely impaired in the presence of an antibody that 
blocks  the  receptor  for  type  I  IFN  (IFN-/  receptor   
[IFNAR]; Fig. S2, A and B). Moreover, co-cultures of NK cells 
and  DCs  lacking  IFNAR  showed  that  NK  cell  activation   
requires IFN- signaling in both NK cells and DCs (Fig. S2, 
C and D). Thus, type I IFNs are required for robust NK cell 
activation. Because MDA5/ mice secrete very little IFN- 
and IFN- in response to poly(I:C), the scarcity of these cyto-
kines is probably responsible for the global defect in NK cell 
activation in MDA5/ mice after stimulation with poly(I:C). 
Although IL-12 stimulates IFN- secretion (Trinchieri, 1995), 
MDA5/ BMDCs also failed to produce adequate amounts of 
IFN-, although a very minor IFN- response was detectable 
early after poly(I:C) stimulation (Fig. 3 D). The IFN- response 
was partially reduced in TLR3/ BMDCs and completely 
abolished in DKO BMDCs. Thus, MDA5 is essential for both 
IFN- and IFN- responses to poly(I:C), whereas TLR3 is 
dispensable for IFN-, although it contributes to IFN- pro-
duction. As opposed to type I IFNs, MDA5/ BMDCs se-
creted WT levels of IL-12p40, whereas TLR3/ BMDCs 
produced essentially no IL-12p40 (Fig. 3 E).
We conclude that MDA5 and TLR3 induce cytokines in 
response to poly(I:C) in different ways. MDA5 is required for 
the  IFN-  and  IFN-  response  to  poly(I:C),  but  not  IL-
12p40. In contrast, TLR3 is required for IL-12p40 and, to a 
Figure 4.  Expression patterns of MDA5 and TLR3 in spleen and liver. (A) Frozen tissue sections from spleen and liver of unstimulated MDA5/ 
and WT mice and from poly(I:C)-injected WT mice were stained with anti-MDA5 (brown) and counterstained with hematoxylin (blue). (B) Formalin-fixed 
sections from spleen and liver of unstimulated TLR3/ and WT mice and poly(I:C)-injected WT mice were stained with anti-TLR3 (brown) and counter-
stained with hematoxylin (blue; experiments were performed using organs from two unstimulated and four poly(I:C)-stimulated mice for each genotype 
with staining done at least in duplicate for each). Expression of TLR3 in the B cell area of the spleen was confirmed by staining with anti-B220 and anti-
CD3 (not depicted). WP, white pulp; RP, red pulp. Bars, 100 µm.2972 Distinct roles of MDA5 and TLR3 in NK activation | McCartney et al.
To test the importance of MDA5 and TLR3 in the stro-
mal versus hematopoietic compartments, we created radiation 
chimeras between WT and MDA5/ as well as WT and 
TLR3/ mice. Upon poly(I:C) stimulation, defective NK 
cell–mediated cytotoxicity and reduced serum levels of IFN-
 were seen in MDA5/ chimeras that had received WT 
BM, whereas no cytotoxicity defect and minor impairment of 
systemic IFN- were observed in WT chimeras that had been 
grafted with MDA5/ BM (Fig. 5, A and B). Conversely, 
WT hosts that had received TLR3/ BM showed a slight 
decrease in cytotoxicity and marked reduction of systemic IL-
12p40 compared with WT animals, whereas no obvious cy-
totoxicity  or  systemic  IL-12p40  defects  were  observed  in 
chimeras from TLR3/ hosts grafted with WT BM (Fig. 5, 
A and C). These results indicate that MDA5 activates NK 
cells by acting predominantly in the radio-resistant stromal 
cell  population,  whereas  TLR3  activates  NK  cells  mainly 
through radio-sensitive hematopoietic accessory cells.
Poly(I:C)-mediated NK cell activation in vivo occurs 
independently of CD8 DCs
Because TLR3 is highly expressed in CD8 DCs (Edwards et 
al., 2003) and CD8 DCs specialize in the secretion of IL-12 
(Maldonado-López et al., 1999), it seemed plausible that the 
hematopoietic accessory cells involved in TLR3-induced NK 
cell activation were, in fact, CD8 DCs. This possibility was 
further supported by a recent study showing that poly(I:C) trig-
gers the TRIF and IPS1 signaling pathways in CD8 DCs, in-
ducing the secretion of IL-12 and type I IFNs that activate NK 
cells in vitro (Miyake et al., 2009). To directly test the contribu-
tion of CD8 DCs to poly(I:C)-mediated NK cell activation in 
vivo, we analyzed Batf3/ mice, which selectively lack the 
CD8 DC population (Hildner et al., 2008). After injection of 
poly(I:C), NK cells isolated from Batf3/ killed RMA-S cells 
only slightly less efficiently than WT NK cells (Fig. 6 A). Up-
regulation of CD69, NK cell secretion of IFN-, serum IFN-, 
and serum IL-12p40 were similar in Batf3/ and WT mice 
(Fig.  6,  B–E).  These  results  indicate  that  poly(I:C)  triggers   
secretion of NK cell stimulatory cytokines through multiple   
accessory cells rather than solely through CD8 DCs.
the addition of an antibody neutralizing IL-12 to co-cultures 
of  NK  cells  and  DCs  had  minimal  impact  on  poly(I:C)- 
induced NK cell secretion of IFN- (Fig. S2, A and B). Thus,   
the partial defect in IFN- secretion observed in TLR3/ 
mice may be caused by insufficient IFN-, perhaps com-
bined  with  the  lack  of  IL-12  and/or  other  cytokines 
(Matikainen et al., 2001). As yet undefined TLR3-induced 
cell–cell  interactions  might  also  contribute  to  NK  cell   
secretion of IFN-.
MDA5 and TLR3 function in different accessory  
cell populations
Our data indicate that MDA5 and TLR3 have distinct quantita-
tive and qualitative impacts on NK cell activation by poly(I:C). 
One potential explanation for this is differential expression of 
MDA5 and TLR3 in cell types that have distinct capacities to 
produce cytokines. To address this possibility, we investigated 
the expression of MDA5 and TLR3 in the spleen and liver 
before and after poly(I:C) stimulation by immunohistochemistry. 
In naive mice, MDA5 was broadly expressed in the red pulp 
and T cell area of the spleen and in the hepatocytes and interstitial 
cells of the liver (Fig. 4 A). In contrast, TLR3 expression was 
more limited, including DCs of the white pulp, rare lymphoid 
cells in the marginal zone, red pulp macrophages, and liver inter-
stitial cells, likely corresponding to Kupffer cells and endothelial 
lining cells (Fig. 4 B). Poly(I:C) stimulation induced a very 
strong increase in MDA5 expression in both spleen and liver, 
with the only notable exception in the splenic B cell area 
(Fig. 4 A). Poly(I:C) stimulation also induced broader expres-
sion of TLR3 in the spleen, particularly in the B cell area, and 
in the liver, including the hepatocytes (Fig. 4 B). These results 
suggested that MDA5 and TLR3 are constitutively expressed 
in partially distinct cellular compartments of the spleen and 
liver, with MDA5 being more broadly expressed than TLR3.   
Administration of poly(I:C) stimulates a stronger and broader 
expression of both sensors, consistent with previous studies 
showing that type I IFNs induce MDA5 (Ishii et al., 2008) and 
TLR3 expression (Matsumoto and Seya, 2008). Even under 
these conditions, however, the distribution of MDA5 and 
TLR3 does not entirely overlap.
Figure 5.  MDA5 and TLR3 act in different cellular compartments. BM chimeras consisting of WT>MDA5/, MDA5/>WT, WT>TLR3/, and 
TLR3/>WT mice were stimulated with 100 µg poly(I:C) i.v. After 24 h, splenocytes were harvested and used as effector cells in cytotoxicity assays 
against Cr51-labeled RMA-S targets (experiments were performed using one mouse for each chimera in three independent trials; A). Additionally, serum 
was collected to measure systemic IFN- (B) and IL-12p40 (C; experiments were performed with serum from four mice of each chimera in one indepen-
dent ELISA assay). Statistical significance is indicated by **, P < 0.001. Error bars represent SD.JEM VOL. 206, December 21, 2009  2973
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DCs, whereas deficiency of MDA5 and/or TLR3 in DCs 
impairs activation of WT NK cells. Similar results were re-
cently  obtained  by  Miyake  et  al.  (2009).  Moreover,  the 
extrinsic function of MDA5 was further supported by in vivo 
experiments showing that poly(I:C)-mediated NK cell acti-
vation is normal in lethally irradiated WT mice reconstituted 
with MDA5/ BM cells, which generate MDA5/ NK 
cells.  Although  MDA5  is  ubiquitously  induced  by  type  I 
IFNs and therefore may be also expressed in NK cells, NK 
cells most likely lack efficient mechanisms for poly(I:C) up-
take, thereby preventing a direct effect of poly(I:C) on NK 
cells. It remains possible that the administration of poly(I:C) 
with  liposomal  reagents  that  facilitate  cytosolic  entry  of 
poly(I:C) may induce some direct activation of NK cells.
MDA5 and TLR3 contributed to poly(I:C)-induced NK 
cell activation by inducing different NK cell stimulatory cy-
tokines.  MDA5  promoted  IFN-  and  IFN-  secretion, 
whereas TLR3 was essential for IL-12p40 and, in part, for 
Concluding remarks
In this study, we provide the first demonstration that MDA5 
is essential for robust activation of mouse NK cells in response 
to poly(I:C). Although previously published studies have sug-
gested  that  poly(I:C)  activates  NK  cells  primarily  through 
TLR3, our data show that MDA5 is, in fact, more important 
than TLR3 for triggering all NK cell functions, including cy-
totoxicity, CD69, and IFN- production. TLR3 has a minor 
impact on NK cell activation, and its role is most evident in 
DKO mice, in which the lack of MDA5 and TLR3 com-
pletely abrogates the NK cell response to poly(I:C). This result 
also excludes any contribution of other dsRNA sensors, such 
as RIG-I, to poly(I:C)-mediated NK cell activation.
We demonstrated that MDA5- and TLR3-mediated NK 
cell activation is NK cell extrinsic. This conclusion is sup-
ported by in vitro experiments showing that lack of both 
MDA5 and TLR3 in NK cells has no impact on the ability of 
poly(I:C) to induce NK cell activation in the presence of WT 
Figure 6.  Poly (I:C)-induced NK cell activation is independent of CD8 DCs. WT and Batf3/ mice were injected with 100 µg poly(I:C) i.v. After 
24 h, splenocytes were harvested and used as effector cells in a cytotoxicity assay with labeled RMA-S targets (experiments were performed using one 
mouse for each genotype in three independent trials; A) or assayed for CD69 expression by FACS, gating on DX5+CD3 splenocytes (experiments were 
performed using two mice for each genotype in two independent trials; B). Alternatively, 3 h after poly(I:C) injection, splenocytes were isolated and cul-
tured with monensin for an additional 3 h, at which time DX5+CD3 cells were analyzed by FACS for intracellular IFN- content (experiments were per-
formed using one mouse for each genotype in three independent trials; C). Serum samples from poly(I:C)-injected mice were taken at 24 h, and IFN-  
(D) and IL-12p40 (E) were measured by ELISA (experiments were performed with serum from four mice of each chimera in one independent ELISA assay). 
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TLR3 expression suggests that these cells may include various 
DCs and macrophage subsets in the white and the red pulp of 
the spleen as well as marginal zone B cells. In conclusion, our 
experiments elucidate the mechanisms by which poly(I:C) ac-
tivates NK cells in vivo, demonstrating distinct yet comple-
mentary roles for MDA5 and TLR3 in stimulating NK cell 
effector functions through a multiplicity of accessory cells.
MATERIALS AND METHODS
Mice, cell lines, antibodies, and poly(I:C). MDA5/, TLR3/, and 
IFNAR/ mice have been described previously (Alexopoulou et al., 2001; 
Trumpfheller et al., 2008). DKO mice were made by intercrossing MDA5/ 
and TLR3/ mice. These mice have been backcrossed to the C57BL/6 
background. Age- and sex-matched C57BL/6 control mice were purchased 
from Jackson ImmunoResearch Laboratories, Inc. Batf3/ (Hildner et al., 
2008) and WT (Taconic) mice were on the 129SvEv background except for 
those used for IFN- staining, which were backcrossed six times onto the 
C57BL/6 background. All mouse protocols were approved by the Washing-
ton University Animal Care Committee. RMA-S cells were maintained in 
RPMI 1640 supplemented with 10% FCS, penicillin/streptomycin, and glu-
tamax. Blocking antibodies included anti-IFNAR (MAR1-5A3), anti–IL-12 
(Tosh; provided by E.R. Unanue, Department of Pathology and Immunol-
ogy, Washington University School of Medicine, St Louis, MO), and anti-
human  IFN-  receptor  (GIR-208)  as  isotype  control.  High  molecular 
weight poly(I:C) was obtained from InvivoGen.
BM chimeras. Recipient mice were  irradiated with 1,000 rad. After an 
overnight rest, mice were reconstituted with 5 × 106 BM cells per mouse 
that had been harvested from the femurs and tibias of age- and sex-matched 
donors. After 6 wk, chimeras were used for in vivo poly(I:C) stimulations.
Cell preparations. Single-cell suspensions were prepared from spleens and 
depleted of erythrocytes by ammonium chloride lysis. For NK purification, 
cell suspensions were incubated with anti-DX5–coated MACS beads (Miltenyi 
Biotec) and purified by autoMACS. Primary cells were cultured in complete 
media (RPMI 1640 without l-glutamine supplemented with 10% FCS,   
sodium pyruvate, kanamycin sulfate, glutamax, and nonessential amino acids). 
BMDCs were cultured in complete media with 2% GM-CSF for 7 d and used 
in assays with complete media.
NK-DC co-cultures. For NK-DC cell co-culture experiments, 105 BMDCs 
were cultured with 5 × 104 NK cells in the presence or absence of 25 µg 
poly(I:C). In some experiments, anti-IFNAR, anti–IL-12p70, or control 
antibody was added to the cultures before the addition of the poly(I:C). In 
other experiments, purified NK cells alone were stimulated with 0, 25, or 
100 µg poly(I:C) in the presence of 200, 1,000, or 5,000 U IFN- (PBL In-
terferon Source); 1, 10, or 100 ng/ml IL-12 (PeproTech); or 1 ng/ml each 
of IL-12 and IL-18 (PeproTech). After 24 h, supernatants were harvested for 
cytokine detection, and NK cells were detached by washing with 1 mM 
EDTA in PBS and were analyzed by FACS.
Cytotoxicity  assays. To measure NK cytotoxicity ex vivo, splenocytes 
were prepared as described previously (see Cell preparations section) 24 h after 
injecting mice with 100 µg poly(I:C) i.v. and were mixed with 105 Cr51-
labeled RMA-S targets in decreasing effector/target ratios. To measure NK 
cytotoxicity in NK-DC co-cultures, Cr51-labeled RMA-S targets were directly 
added to the NK-DC co-cultures. After 4 h, supernatants were harvested, and 
Cr51 release was measured in individual samples as well as maximum and 
spontaneous release samples. Specific lysis was calculated by specific release  
spontaneous release/max release  spontaneous release.
FACS analysis. Splenocytes, cultured NK cells, and BMDCs prepared as 
described previously (see Cell preparations section) were treated with Fc 
block (HB-197) and stained with anti-CD3, anti-NK1.1, and anti-CD69 
IFN- production. Our in vitro data indicate that type I 
IFNs are crucial for poly(I:C)-induced NK cell activation. 
These data are consistent with the recent observation that 
NK cell secretion of IFN- in response to poly(I:C) is blocked 
by injection of an anti-IFNAR antibody in vivo (Longhi   
et al., 2009). The crucial role of type I IFNs in poly(I:C)-
mediated NK cell activation, together with the predominant 
function of MDA5 in inducing IFN- and IFN- secretion, 
explains the major defect in NK cell activation in MDA5/ 
mice. Although IL-12 is a known inducer of IFN- (Trinchieri, 
1995), blockade of IL-12 did not affect poly(I:C)-induced 
secretion of IFN- by NK cells, at least in vitro. Therefore, 
the transient defect in NK cell secretion of IFN- observed 
in TLR3/ mice may be caused by insufficient IFN-, per-
haps combined with a defect in IL-12 and/or other cytokines 
(Matikainen et al., 2001). Although our data underscore the 
roles of MDA5 and TLR3 in inducing IFN- and IL-12, 
MDA5 and TLR3 may also act by inducing cell surface mol-
ecules on accessory cells that activate NK cells through cell–
cell interactions or local delivery of cytokines. This is the case 
for the  chain of the IL-15 receptor (IL-15R), which is 
induced by type I IFNs and allows accessory cells to trans-
present IL-15 to NK cells (Koka et al., 2004; Lucas et al., 
2007; Mortier et al., 2008). Accordingly, transcriptional analysis 
of WT, MDA5/, and TLR3/ BMDCs stimulated in 
vitro with poly(I:C) showed that both MDA5 and TLR3 are 
required for the induction of both IL-15R and its ligand 
IL-15 (Fig. S3). MDA5 and TLR3 may induce other cell 
surface molecules on accessory cells involved in NK cell acti-
vation, either indirectly through type I IFN signaling or directly 
through IPS1 and TRIF and their downstream transcription 
factors IRF1/3/7 and NF-B.
Our data indicate that the disparate impacts of MDA5 and 
TLR3 on poly(I:C)-induced secretion of IFN-, IFN-, and 
IL-12p40 and NK cell activation may be related, at least in 
part, to the distinct cellular distribution of MDA5 and TLR3. 
BM chimera experiments demonstrated that MDA5 mainly 
acts through stromal cells. The surfeit of these cells and their 
general ability to produce type I IFNs can explain why MDA5 
stimulation leads to a major release of IFN-. MDA5 may 
have a more limited role in IL-12 secretion because, although 
IFN- induces IL-12p35 (Hermann et al., 1998; Gautier et al., 
2005),  it  also  modulates  IL-12  production  from  DCs  and 
monocytes/macrophages (Nguyen et al., 2000). In contrast, 
TLR3  has  a  more  restricted  distribution  and  acts  mainly 
through hematopoietic cells. This may explain why TLR3 has 
a minor impact on systemic IFN- and a more prominent ef-
fect on IL-12 production. Although CD8 DCs express TLR3 
(Edwards et al., 2003), specialize in the secretion of IL-12 
(Maldonado-López et al., 1999), produce type I IFNs (Longhi 
et al., 2009), and strongly activate NK cells in vitro in response 
to poly(I:C) (Miyake et al., 2009), our analysis of BATF3/ 
mice  that  lack  CD8  DCs  demonstrates  that  poly(I:C)- 
mediated NK cell activation occurs even in the absence of 
these cells, indicating that TLR3 acts through a variety of he-
matopoietic accessory cells. Immunohistochemical analysis of JEM VOL. 206, December 21, 2009  2975
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